GlassScriptPhysician profile
Heather M Saunders
NPI 1720532062
$1,408.47
in general payments reported to CMS, 2019-2025
16 companies · $517 in 2025
The $517 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.41 · 2023: $44.30 · 2024: $809 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $312.01 | 2024-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $157.39 | 2024-2025 | Fanapt, Hetlioz |
| Gilead Sciences, INC. | $152.25 | 2023-2024 | Livdelzi |
| Lundbeck LLC | $122.67 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $115.73 | 2024 | Spravato |
| Abbvie INC. | $112.24 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $78.55 | 2024-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $75.15 | 2024-2025 | Austedo Xr, Austedo Xr |
| Axsome Therapeutics, INC. | $67.57 | 2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $58.54 | 2024-2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $41.03 | 2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $35.14 | 2024-2025 | Aristada, Lybalvi |
| Collegium Pharmaceutical, INC. | $24.94 | 2025 | Jornay Pm |
| Abbott Laboratories | $24.13 | 2022 | |
| Phadia US INC. | $16.65 | 2023 | Immunocap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $14.48 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.